Detalles de la búsqueda
1.
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.
Acta Oncol
; 60(2): 157-164, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33259244
2.
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Breast Cancer Res
; 21(1): 39, 2019 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30867034
3.
Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene.
BMC Cancer
; 19(1): 573, 2019 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31196001
4.
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.
Breast Cancer Res Treat
; 172(2): 391-400, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30099635
5.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(12): 1688-1700, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146401
6.
Medical treatment of advanced breast cancer.
Ugeskr Laeger
; 186(12)2024 03 18.
Artículo
en Da
| MEDLINE | ID: mdl-38533869
7.
Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer.
Clin Chem Lab Med
; 51(7): 1483-92, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23420288
8.
Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA.
Sci Rep
; 13(1): 8419, 2023 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37225860
9.
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer.
Breast Cancer Res Treat
; 133(1): 257-65, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22270936
10.
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial.
Nat Med
; 28(12): 2573-2583, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482103
11.
Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer.
Sci Rep
; 10(1): 16558, 2020 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024132
12.
Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study.
Sci Rep
; 10(1): 6714, 2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32317675
13.
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.
Breast Cancer
; 27(2): 266-276, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31654283
14.
Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting.
Clin Chem Lab Med
; 47(9): 1117-23, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19728854
15.
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
J Clin Oncol
; 37(2): 105-114, 2019 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475668
16.
Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: A retrospective cohort study.
Mol Clin Oncol
; 8(6): 767-772, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29805791
17.
Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial.
J Clin Oncol
; 35(23): 2639-2646, 2017 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28661759
18.
Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification.
J Circ Biomark
; 4: 9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-28936245
19.
New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer.
Transl Oncol
; 7(6): 694-701, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25500078
20.
[Prevention of skeletal related events in patients with bone metastases from solid tumours]. / Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer.
Ugeskr Laeger
; 176(8A): V08130525, 2014 Feb 17.
Artículo
en Da
| MEDLINE | ID: mdl-25350304